A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation
Clinical trial NCT02333513 · UNKNOWN
Trial details
- NCT number
- NCT02333513
- Sponsor
- Hebei Yanda Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.